New brain scan sheds light on Parkinson's and aging
NCT ID NCT07569120
First seen Jun 25, 2026 · Last updated Jul 10, 2026 · Updated 4 times
Summary
This study uses advanced PET/MRI scanning to examine the noradrenaline system in the brains of 165 healthy adults and people with Parkinson's disease. Participants receive a radioactive tracer that binds to specific receptors, allowing researchers to see how this system changes with age and disease. The goal is to link these brain changes to thinking, memory, and movement abilities.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- [11C]ORM-13070 (a radioactive tracer for PET scans)
- What this could lead to
- If successful, this could reveal how the noradrenaline system changes with age and in Parkinson's, potentially guiding future treatments for cognitive and motor symptoms.
- What could go wrong
- This is an observational imaging study, not a treatment trial. It is early-stage and may not directly lead to new therapies. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY AGING AND PARKINSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Neurologique Pierre Wertheimer - Service de Neurologie
RECRUITINGBron, 69500, France